|
|
|
Insider
Information: |
Nanavaty Maulik |
Relationship: |
|
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
177,758 |
|
Indirect Shares
|
11,017 |
|
|
Direct
Value |
$13,668,364 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
188,775 |
|
|
Total
Value |
$13,668,364 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
6.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2013-02-16 |
4 |
D |
$7.54 |
$7,005 |
D/D |
(929) |
69,485 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2012-10-30 |
4 |
D |
$5.17 |
$8,686 |
D/D |
(1,680) |
65,272 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, Neuromodula |
|
2011-10-31 |
4 |
D |
$5.81 |
$9,703 |
D/D |
(1,670) |
48,246 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2012-02-12 |
4 |
D |
$5.93 |
$9,802 |
D/D |
(1,653) |
51,984 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2016-02-23 |
4 |
D |
$17.24 |
$11,930 |
D/D |
(692) |
169,040 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2014-02-16 |
4 |
D |
$13.30 |
$12,356 |
D/D |
(929) |
81,718 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2015-02-16 |
4 |
D |
$14.98 |
$13,871 |
D/D |
(926) |
113,645 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2015-02-24 |
4 |
D |
$16.62 |
$16,720 |
D/D |
(1,006) |
127,032 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2017-02-23 |
4 |
D |
$24.48 |
$16,940 |
D/D |
(692) |
186,621 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2013-02-27 |
4 |
D |
$7.33 |
$17,130 |
D/D |
(2,337) |
74,852 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2018-02-22 |
4 |
D |
$26.48 |
$17,265 |
D/D |
(652) |
227,452 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2016-02-24 |
4 |
D |
$17.33 |
$17,434 |
D/D |
(1,006) |
170,710 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2017-02-22 |
4 |
D |
$25.16 |
$17,813 |
D/D |
(708) |
185,474 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2013-02-12 |
4 |
D |
$7.59 |
$17,966 |
D/D |
(2,367) |
68,298 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2016-02-27 |
4 |
D |
$17.21 |
$18,294 |
D/D |
(1,063) |
172,036 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2018-02-23 |
4 |
D |
$27.20 |
$21,842 |
D/D |
(803) |
228,488 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-28 |
4 |
D |
$38.78 |
$21,872 |
D/D |
(564) |
245,061 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-15 |
4 |
D |
$38.39 |
$22,074 |
D/D |
(575) |
240,482 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-01-15 |
4 |
OE |
$7.41 |
$22,512 |
D/D |
3,038 |
243,206 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-03-15 |
4 |
OE |
$7.41 |
$22,512 |
D/D |
3,038 |
257,507 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-05-15 |
4 |
OE |
$7.41 |
$22,512 |
D/D |
3,038 |
257,507 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-02-15 |
4 |
OE |
$0.00 |
$22,519 |
D/D |
4,700 |
244,868 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-04-15 |
4 |
OE |
$7.41 |
$22,519 |
D/D |
3,039 |
257,508 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-06-17 |
4 |
OE |
$7.41 |
$22,519 |
D/D |
3,039 |
257,508 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-21 |
4 |
D |
$38.03 |
$22,552 |
D/D |
(593) |
242,765 |
0 |
- |
|
176 Records found
|
|
Page 4 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|